Essential myosin light chain as a target for caspase-3 in failing myocardium

Programmed cell death involves the activation of caspase proteases that can mediate the cleavage of vital cytoskeletal proteins. We have recently reported that, in failing cardiac myocytes, caspase-3 activation is associated with a reduction in contractile performance. In this study we used a modified yeast two-hybrid system to screen for caspase-3 interacting proteins of the cardiac cytoskeleton. We identified ventricular essential myosin light chain (vMLC1) as a target for caspase-3. By sequencing and site-directed mutagenesis, a noncanonical cleavage site for caspase-3 was mapped to the C-terminal DFVE135G motif. We demonstrated that vMLC1 cleavage in failing myocardium in vivo is associated with a morphological disruption of the organized vMLC1 staining of sarcomeres, and with a reduction in myocyte contractile performance. Adenoviral gene transfer of the caspase inhibitor p35 in vivo prevented caspase-3 activation and vMLC1 cleavage, with positive impact on contractility. These data suggest that direct cleavage of vMLC1 by activated caspase-3 may contribute to depression of myocyte function by altering cross-bridge interaction between myosin and actin molecules. Therefore, activation of apoptotic pathways in the heart may lead to contractile dysfunction before cell death.

[1]  Emad S. Alnemri,et al.  A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis , 2001, Nature.

[2]  O. Hess,et al.  Hemodynamic performance and myosin light chain-1 expression of the hypertrophied left ventricle in aortic valve disease before and after valve replacement. , 1992, Circulation research.

[3]  K. Trybus,et al.  Skeletal muscle myosin light chains are essential for physiological speeds of shortening , 1993, Nature.

[4]  P. Anversa,et al.  Oxidative Stress–Mediated Cardiac Cell Death Is a Major Determinant of Ventricular Dysfunction and Failure in Dog Dilated Cardiomyopathy , 2001, Circulation research.

[5]  R. Kraft,et al.  Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1. , 2001 .

[6]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[7]  Y. Tsujimoto,et al.  A cloning method for caspase substrates that uses the yeast two-hybrid system: cloning of the antiapoptotic gene gelsolin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Frank,et al.  Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. , 1996, The New England journal of medicine.

[9]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[10]  R. Virmani,et al.  Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D A Winkelmann,et al.  Three-dimensional structure of myosin subfragment-1: a molecular motor. , 1993, Science.

[12]  M. Whittaker,et al.  Molecular structure of F-actin and location of surface binding sites , 1990, Nature.

[13]  P. D. de Tombe,et al.  Functional consequences of caspase activation in cardiac myocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Trybus,et al.  The essential light chain is required for full force production by skeletal muscle myosin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[16]  T. Schöneberg,et al.  Adenoviral gene transfer of the human V2 vasopressin receptor improves contractile force of rat cardiomyocytes. , 1999, Circulation.

[17]  K. Chien.  Genomic circuits and the integrative biology of cardiac diseases , 2000, Nature.

[18]  E. Peterson,et al.  The Drosophila caspase DRONC cleaves following glutamate or aspartate and is regulated by DIAP1, HID, and GRIM. , 2000, The Journal of biological chemistry.

[19]  Jean X. Jiang,et al.  The Development-associated Cleavage of Lens Connexin 45.6 by Caspase-3-like Protease Is Regulated by Casein Kinase II-mediated Phosphorylation* , 2001, The Journal of Biological Chemistry.

[20]  I. Morano.  Tuning the human heart molecular motors by myosin light chains , 1999, Journal of Molecular Medicine.

[21]  E. Bossy‐Wetzel,et al.  Caspase 7 can cleave tumor necrosis factor receptor-I (p60) at a non-consensus motif, in vitro. , 2001, Biochimica et biophysica acta.

[22]  M. Seyfarth,et al.  Blocking caspase-activated apoptosis improves contractility in failing myocardium. , 2001, Human gene therapy.

[23]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[24]  S. Izumo,et al.  Apoptosis: basic mechanisms and implications for cardiovascular disease. , 1998, Circulation research.

[25]  J. Mankovich,et al.  Substrate Specificities of Caspase Family Proteases* , 1997, The Journal of Biological Chemistry.

[26]  M. Böhm,et al.  Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failing human heart. , 1997, Journal of molecular and cellular cardiology.

[27]  W. Littler,et al.  Human atrial and ventricular myosin light-chains subunits in the adult and during development. , 1980, The Biochemical journal.

[28]  I. Rayment,et al.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle , 1996, Nature Genetics.